Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Wyeth

Status and phase: Completed; Phase 3

Conditions: Depression

Treatments: Drug: Effexor XR

Study type: Interventional

Funder types: Industry

Identifiers

NCT00225485

0600B1-817

Details and patient eligibility

About

Phase III study evaluating Effexor XR in elderly patients with major depression.

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with major depression based on DSM-IV-TR
• Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" of HAM-D at baseline

Exclusion criteria

• Patients with schizophrenia or any other psychotic disorder
• Patients with history or presence of bipolar disorder

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)